Affirm Holdings, Inc. (NASDAQ:AFRM – Get Free Report) COO Michael Linford sold 79,219 shares of the business’s stock in a transaction that occurred on Friday, August 28th. The stock was sold at an average price of $90.01, for a total value of $7,130,502.19. Following the transaction, the chief operating officer directly owned 120,713 shares in the company, valued at $10,865,377.13. This trade represents a 39.62% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Michael Linford also recently made the following trade(s):
- On Friday, June 26th, Michael Linford sold 100,000 shares of Affirm stock. The shares were sold at an average price of $80.04, for a total transaction of $8,004,000.00.
Affirm Stock Down 6.1%
AFRM stock opened at $69.94 on Wednesday. The business’s fifty day moving average price is $77.45 and its two-hundred day moving average price is $64.84. The stock has a market capitalization of $23.42 billion, a price-to-earnings ratio of 12.67, a PEG ratio of 2.91 and a beta of 3.61. Affirm Holdings, Inc. has a fifty-two week low of $42.10 and a fifty-two week high of $93.20. The company has a debt-to-equity ratio of 1.82, a current ratio of 11.80 and a quick ratio of 11.80.
Institutional Inflows and Outflows
Several large investors have recently modified their holdings of AFRM. Greenline Wealth Management LLC purchased a new position in Affirm in the 4th quarter worth approximately $26,000. Syntegra Private Wealth Group LLC purchased a new stake in shares of Affirm during the first quarter valued at approximately $28,000. Triumph Capital Management bought a new position in shares of Affirm in the third quarter worth approximately $31,000. Strive Financial Group LLC purchased a new position in shares of Affirm in the fourth quarter worth $33,000. Finally, Fideuram Intesa Sanpaolo Private Banking S.P.A. purchased a new position in shares of Affirm in the first quarter worth $34,000. Hedge funds and other institutional investors own 69.29% of the company’s stock.
Analyst Ratings Changes
Several research analysts have weighed in on AFRM shares. Stephens boosted their price objective on Affirm from $55.00 to $75.00 and gave the stock an “equal weight” rating in a research report on Friday, May 8th. Wolfe Research reiterated an “outperform” rating on shares of Affirm in a research note on Friday. JPMorgan Chase & Co. raised their price target on shares of Affirm from $90.00 to $105.00 and gave the stock an “overweight” rating in a research note on Friday, August 28th. Robert W. Baird upped their price objective on Affirm from $70.00 to $82.00 and gave the company a “neutral” rating in a research note on Tuesday, July 14th. Finally, Truist Financial increased their price objective on Affirm from $80.00 to $83.00 and gave the company a “buy” rating in a report on Friday, July 24th. Twenty-two investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $99.20.
Get Our Latest Analysis on AFRM
Affirm Company Profile
Affirm Holdings, Inc is a financial technology company that provides point-of-sale consumer lending and payments solutions for online and in-store purchases. Its core product is a buy-now-pay-later (BNPL) platform that enables consumers to split purchases into fixed, transparent installment loans with no hidden fees. Affirm offers a range of financing options through merchant integrations, a consumer-facing mobile app and virtual card capabilities, and tools for merchants to offer alternative payment methods at checkout.
Featured Articles
- Five stocks we like better than Affirm
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for Affirm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Affirm and related companies with MarketBeat.com's FREE daily email newsletter.
